HopeStage
Back to all studies
RecruitingNCT07031817

Blood markers and a questionnaire to assess bipolarity

About this title

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Read the official source — NCT07031817
Study assessmentsAges 18–65France
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

The protocol includes: Providing blood samples.

Listed locations
MontpellierSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 30, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
623
Sponsor
University Hospital, Montpellier
Sponsor type
Hospital / academic medical center
Study type
Diagnostic Test
Intervention type
DIAGNOSTIC_TEST, OTHER
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 65 Years
Official registry ID
NCT07031817
Official title
Show the full official title

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder in Patients With a Characterized Depressive Episode in Primary Care

Recruitment & locations

Recruiting

Montpellier

A listed location does not confirm current availability.

FAQ

Questions about this study

What will I need to do?

You will provide blood samples.

Who is behind this study?

The study sponsor is University Hospital, Montpellier, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies